Evgenia Dobrinskikh
Concepts (409)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mucin-5B | 12 | 2026 | 234 | 2.750 |
Why?
| | Idiopathic Pulmonary Fibrosis | 15 | 2026 | 697 | 2.190 |
Why?
| | Lung | 14 | 2026 | 4122 | 1.490 |
Why?
| | Hernias, Diaphragmatic, Congenital | 3 | 2020 | 188 | 1.440 |
Why?
| | Acetaminophen | 4 | 2025 | 268 | 1.430 |
Why?
| | Lung Injury | 4 | 2026 | 263 | 1.360 |
Why?
| | Fetus | 5 | 2025 | 800 | 1.090 |
Why?
| | Bleomycin | 6 | 2026 | 255 | 1.080 |
Why?
| | Liver | 9 | 2026 | 1864 | 0.890 |
Why?
| | Endocytosis | 4 | 2014 | 170 | 0.780 |
Why?
| | Respiratory Mucosa | 3 | 2025 | 323 | 0.710 |
Why?
| | Podocytes | 6 | 2019 | 80 | 0.700 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2021 | 266 | 0.700 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIa | 2 | 2013 | 9 | 0.700 |
Why?
| | Kidney Tubules, Proximal | 2 | 2013 | 127 | 0.650 |
Why?
| | Animals | 50 | 2026 | 38107 | 0.640 |
Why?
| | Idiopathic Interstitial Pneumonias | 1 | 2020 | 44 | 0.620 |
Why?
| | Therapeutic Occlusion | 1 | 2020 | 3 | 0.620 |
Why?
| | Fetal Therapies | 1 | 2020 | 48 | 0.580 |
Why?
| | Glycolysis | 4 | 2021 | 342 | 0.550 |
Why?
| | Organogenesis | 1 | 2019 | 63 | 0.550 |
Why?
| | Serum Albumin | 3 | 2019 | 147 | 0.540 |
Why?
| | Nerve Tissue Proteins | 2 | 2013 | 597 | 0.530 |
Why?
| | Tracheal Stenosis | 1 | 2018 | 38 | 0.520 |
Why?
| | Liver Cirrhosis | 3 | 2025 | 278 | 0.520 |
Why?
| | Airway Obstruction | 1 | 2019 | 152 | 0.510 |
Why?
| | Disease Models, Animal | 13 | 2026 | 4580 | 0.470 |
Why?
| | Diet, Western | 4 | 2025 | 89 | 0.460 |
Why?
| | Fluorescein-5-isothiocyanate | 3 | 2014 | 34 | 0.460 |
Why?
| | Mice | 25 | 2026 | 18297 | 0.440 |
Why?
| | Gene Expression Regulation | 4 | 2021 | 2599 | 0.430 |
Why?
| | Endoplasmic Reticulum Stress | 3 | 2026 | 120 | 0.420 |
Why?
| | Fetal Growth Retardation | 3 | 2025 | 592 | 0.420 |
Why?
| | Oxidative Phosphorylation | 3 | 2021 | 212 | 0.420 |
Why?
| | Caveolae | 1 | 2014 | 15 | 0.410 |
Why?
| | Cytochrome P-450 CYP2E1 | 3 | 2025 | 30 | 0.400 |
Why?
| | Rabbits | 3 | 2020 | 651 | 0.390 |
Why?
| | Bile Acids and Salts | 4 | 2025 | 163 | 0.370 |
Why?
| | Receptors, G-Protein-Coupled | 4 | 2022 | 233 | 0.360 |
Why?
| | Cysts | 2 | 2022 | 108 | 0.310 |
Why?
| | Pregnancy | 12 | 2025 | 7230 | 0.300 |
Why?
| | Kidney | 4 | 2019 | 1498 | 0.300 |
Why?
| | Non-alcoholic Fatty Liver Disease | 2 | 2023 | 265 | 0.290 |
Why?
| | Optical Imaging | 2 | 2021 | 63 | 0.280 |
Why?
| | Diabetic Nephropathies | 3 | 2017 | 320 | 0.280 |
Why?
| | Pulmonary Surfactants | 2 | 2020 | 105 | 0.280 |
Why?
| | Signal Transduction | 12 | 2026 | 5246 | 0.280 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 3 | 2025 | 213 | 0.270 |
Why?
| | Lysosomes | 3 | 2014 | 134 | 0.270 |
Why?
| | Hepacivirus | 3 | 2015 | 237 | 0.260 |
Why?
| | Trachea | 2 | 2020 | 253 | 0.260 |
Why?
| | Hypoxia | 2 | 2025 | 1211 | 0.250 |
Why?
| | Placental Insufficiency | 2 | 2025 | 126 | 0.250 |
Why?
| | Extracellular Matrix | 2 | 2021 | 565 | 0.250 |
Why?
| | SOXC Transcription Factors | 1 | 2026 | 9 | 0.240 |
Why?
| | Receptors, Fc | 2 | 2019 | 54 | 0.230 |
Why?
| | Bronchioles | 1 | 2026 | 29 | 0.230 |
Why?
| | Muscle, Striated | 1 | 2026 | 12 | 0.230 |
Why?
| | Vero Cells | 1 | 2006 | 84 | 0.230 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2026 | 80 | 0.230 |
Why?
| | Pseudopodia | 1 | 2006 | 25 | 0.230 |
Why?
| | Sheep | 5 | 2026 | 870 | 0.230 |
Why?
| | Muscle Fibers, Slow-Twitch | 1 | 2025 | 25 | 0.230 |
Why?
| | Intestinal Mucosa | 3 | 2017 | 666 | 0.230 |
Why?
| | Vascular Remodeling | 2 | 2025 | 208 | 0.220 |
Why?
| | Microvessels | 1 | 2026 | 98 | 0.210 |
Why?
| | Female | 26 | 2026 | 79499 | 0.210 |
Why?
| | Capillaries | 1 | 2025 | 123 | 0.210 |
Why?
| | Fetal Hypoxia | 1 | 2025 | 56 | 0.210 |
Why?
| | Biliary Atresia | 1 | 2026 | 162 | 0.210 |
Why?
| | Humans | 42 | 2026 | 146342 | 0.210 |
Why?
| | Glucagon | 1 | 2025 | 114 | 0.200 |
Why?
| | Chorionic Villi | 1 | 2024 | 24 | 0.200 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2025 | 178 | 0.200 |
Why?
| | Microtubules | 1 | 2006 | 226 | 0.200 |
Why?
| | Microglia | 2 | 2024 | 289 | 0.200 |
Why?
| | Umbilical Arteries | 1 | 2024 | 51 | 0.200 |
Why?
| | Metabolomics | 2 | 2020 | 738 | 0.200 |
Why?
| | Microscopy, Fluorescence | 2 | 2016 | 404 | 0.190 |
Why?
| | Cell Line | 5 | 2017 | 2814 | 0.190 |
Why?
| | Eukaryotic Initiation Factor-2B | 1 | 2023 | 6 | 0.190 |
Why?
| | Hypertension, Pregnancy-Induced | 1 | 2024 | 69 | 0.190 |
Why?
| | Macrophages, Alveolar | 1 | 2026 | 377 | 0.190 |
Why?
| | Sirtuin 3 | 1 | 2023 | 60 | 0.190 |
Why?
| | Fibrosis | 6 | 2023 | 568 | 0.190 |
Why?
| | Hypertension, Pulmonary | 2 | 2025 | 1957 | 0.190 |
Why?
| | Saccharopolyspora | 1 | 2022 | 6 | 0.180 |
Why?
| | Endotoxemia | 1 | 2023 | 85 | 0.180 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2024 | 320 | 0.180 |
Why?
| | Diabetes Mellitus, Experimental | 3 | 2019 | 198 | 0.180 |
Why?
| | Mice, Knockout | 7 | 2026 | 3125 | 0.180 |
Why?
| | Receptors, Lysophosphatidic Acid | 1 | 2022 | 40 | 0.180 |
Why?
| | Leukocytes | 1 | 2024 | 301 | 0.180 |
Why?
| | Male | 20 | 2026 | 73396 | 0.180 |
Why?
| | Primates | 4 | 2024 | 133 | 0.180 |
Why?
| | Kidney Diseases | 2 | 2017 | 428 | 0.180 |
Why?
| | Gain of Function Mutation | 2 | 2018 | 35 | 0.170 |
Why?
| | Genetic Predisposition to Disease | 5 | 2026 | 2488 | 0.170 |
Why?
| | Ductus Arteriosus, Patent | 1 | 2022 | 49 | 0.170 |
Why?
| | Assisted Circulation | 1 | 2021 | 26 | 0.170 |
Why?
| | Mice, Inbred ICR | 1 | 2021 | 103 | 0.170 |
Why?
| | Alveolitis, Extrinsic Allergic | 1 | 2022 | 96 | 0.170 |
Why?
| | Bone Marrow | 1 | 2023 | 310 | 0.170 |
Why?
| | Heart Murmurs | 1 | 2021 | 13 | 0.170 |
Why?
| | Cell Movement | 1 | 2006 | 951 | 0.170 |
Why?
| | Rats | 6 | 2019 | 5586 | 0.170 |
Why?
| | Amino Acids | 1 | 2025 | 515 | 0.160 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2022 | 145 | 0.160 |
Why?
| | Phosphates | 2 | 2013 | 175 | 0.160 |
Why?
| | Phenotype | 3 | 2024 | 3206 | 0.160 |
Why?
| | Placenta | 2 | 2025 | 794 | 0.160 |
Why?
| | Kidney Tubules | 2 | 2019 | 117 | 0.160 |
Why?
| | Epithelium | 1 | 2021 | 295 | 0.160 |
Why?
| | Aortic Diseases | 1 | 2021 | 125 | 0.160 |
Why?
| | Hepatitis C | 2 | 2015 | 251 | 0.150 |
Why?
| | Cholic Acids | 2 | 2017 | 13 | 0.150 |
Why?
| | Hematopoietic Stem Cells | 1 | 2023 | 432 | 0.150 |
Why?
| | Neurodegenerative Diseases | 1 | 2021 | 147 | 0.150 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2021 | 219 | 0.150 |
Why?
| | NF-kappa B | 1 | 2023 | 674 | 0.140 |
Why?
| | Molecular Imaging | 1 | 2019 | 58 | 0.140 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2019 | 143 | 0.140 |
Why?
| | Lipoxygenase Inhibitors | 1 | 2019 | 34 | 0.140 |
Why?
| | Orthomyxoviridae Infections | 1 | 2019 | 72 | 0.140 |
Why?
| | Mice, Inbred C57BL | 8 | 2025 | 6034 | 0.140 |
Why?
| | Artificial Intelligence | 1 | 2024 | 389 | 0.140 |
Why?
| | Mucociliary Clearance | 1 | 2018 | 44 | 0.140 |
Why?
| | Ventricular Remodeling | 1 | 2021 | 283 | 0.140 |
Why?
| | Cellular Senescence | 1 | 2021 | 225 | 0.140 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 2 | 2022 | 344 | 0.140 |
Why?
| | Muscle, Skeletal | 2 | 2026 | 1818 | 0.140 |
Why?
| | Rats, Sprague-Dawley | 3 | 2014 | 2537 | 0.140 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2025 | 665 | 0.130 |
Why?
| | Biomarkers | 3 | 2021 | 4340 | 0.130 |
Why?
| | Organ Size | 1 | 2019 | 465 | 0.130 |
Why?
| | Desoxycorticosterone Acetate | 1 | 2017 | 4 | 0.130 |
Why?
| | Relaxin | 1 | 2017 | 18 | 0.130 |
Why?
| | Telomere | 1 | 2021 | 300 | 0.130 |
Why?
| | Lipid Metabolism | 2 | 2022 | 533 | 0.130 |
Why?
| | 5'-Nucleotidase | 1 | 2017 | 49 | 0.130 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2019 | 207 | 0.130 |
Why?
| | Alzheimer Disease | 1 | 2024 | 641 | 0.130 |
Why?
| | Nanotubes, Carbon | 1 | 2017 | 48 | 0.130 |
Why?
| | Glucuronidase | 1 | 2017 | 27 | 0.130 |
Why?
| | Salmonella enterica | 1 | 2017 | 52 | 0.130 |
Why?
| | Arrhythmias, Cardiac | 1 | 2020 | 358 | 0.120 |
Why?
| | Gangliosides | 1 | 2017 | 23 | 0.120 |
Why?
| | Membrane Microdomains | 1 | 2017 | 33 | 0.120 |
Why?
| | Insulin | 2 | 2025 | 2525 | 0.120 |
Why?
| | Nephrosclerosis | 1 | 2016 | 6 | 0.120 |
Why?
| | Protein Transport | 2 | 2019 | 443 | 0.120 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2020 | 357 | 0.120 |
Why?
| | Proteolysis | 2 | 2014 | 174 | 0.120 |
Why?
| | Cell Polarity | 2 | 2014 | 138 | 0.120 |
Why?
| | Adenosine | 1 | 2017 | 256 | 0.110 |
Why?
| | Immunity, Maternally-Acquired | 1 | 2015 | 18 | 0.110 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2020 | 530 | 0.110 |
Why?
| | Myocardium | 2 | 2020 | 948 | 0.110 |
Why?
| | Promoter Regions, Genetic | 4 | 2026 | 1242 | 0.110 |
Why?
| | Heart-Assist Devices | 1 | 2021 | 572 | 0.110 |
Why?
| | Lung Diseases | 1 | 2022 | 787 | 0.110 |
Why?
| | Claudin-1 | 1 | 2015 | 16 | 0.110 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2017 | 372 | 0.110 |
Why?
| | Renal Insufficiency | 1 | 2017 | 173 | 0.110 |
Why?
| | Obesity | 3 | 2019 | 3131 | 0.110 |
Why?
| | Hypoxia-Inducible Factor 1 | 1 | 2015 | 69 | 0.110 |
Why?
| | Clathrin | 2 | 2014 | 26 | 0.110 |
Why?
| | Autocrine Communication | 1 | 2014 | 38 | 0.110 |
Why?
| | Epithelial Cells | 3 | 2018 | 1119 | 0.110 |
Why?
| | Tight Junctions | 1 | 2015 | 87 | 0.110 |
Why?
| | Immunoglobulin G | 1 | 2019 | 901 | 0.110 |
Why?
| | Mitochondria | 4 | 2025 | 997 | 0.100 |
Why?
| | Lysosomal-Associated Membrane Protein 1 | 1 | 2014 | 12 | 0.100 |
Why?
| | Transcytosis | 1 | 2014 | 7 | 0.100 |
Why?
| | Host-Pathogen Interactions | 1 | 2017 | 366 | 0.100 |
Why?
| | Microvilli | 2 | 2012 | 72 | 0.100 |
Why?
| | Interleukin-10 Receptor alpha Subunit | 1 | 2013 | 5 | 0.100 |
Why?
| | Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2013 | 18 | 0.100 |
Why?
| | Colitis | 2 | 2013 | 283 | 0.100 |
Why?
| | Albumins | 1 | 2014 | 120 | 0.100 |
Why?
| | Oxidative Stress | 4 | 2025 | 1369 | 0.100 |
Why?
| | Creatine Kinase | 1 | 2013 | 70 | 0.100 |
Why?
| | Aging | 3 | 2024 | 1996 | 0.100 |
Why?
| | Heart | 1 | 2017 | 626 | 0.100 |
Why?
| | Exosomes | 1 | 2014 | 104 | 0.100 |
Why?
| | Immunity, Innate | 4 | 2023 | 844 | 0.100 |
Why?
| | Fibroblasts | 3 | 2025 | 1034 | 0.100 |
Why?
| | Creatine | 1 | 2013 | 63 | 0.100 |
Why?
| | Protease Inhibitors | 1 | 2014 | 103 | 0.100 |
Why?
| | Interferons | 1 | 2014 | 186 | 0.100 |
Why?
| | Vesicular Transport Proteins | 1 | 2014 | 85 | 0.100 |
Why?
| | Didelphis | 1 | 2013 | 3 | 0.100 |
Why?
| | Transcriptome | 1 | 2020 | 1068 | 0.090 |
Why?
| | Trophoblasts | 1 | 2015 | 219 | 0.090 |
Why?
| | Interferon-gamma | 2 | 2013 | 781 | 0.090 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIb | 1 | 2012 | 8 | 0.090 |
Why?
| | Enterocytes | 1 | 2012 | 13 | 0.090 |
Why?
| | Cell Hypoxia | 1 | 2013 | 249 | 0.090 |
Why?
| | Brain | 2 | 2024 | 2991 | 0.090 |
Why?
| | Sodium-Hydrogen Exchangers | 1 | 2012 | 23 | 0.090 |
Why?
| | Quantitative Trait Loci | 2 | 2026 | 388 | 0.090 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2019 | 640 | 0.090 |
Why?
| | Killer Cells, Natural | 1 | 2015 | 481 | 0.090 |
Why?
| | Lung Diseases, Interstitial | 1 | 2018 | 677 | 0.090 |
Why?
| | Interleukin-10 | 1 | 2013 | 310 | 0.090 |
Why?
| | Virus Replication | 1 | 2014 | 526 | 0.090 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2013 | 180 | 0.080 |
Why?
| | Green Fluorescent Proteins | 1 | 2013 | 408 | 0.080 |
Why?
| | RNA Interference | 1 | 2013 | 472 | 0.080 |
Why?
| | Phosphorus, Dietary | 1 | 2010 | 4 | 0.080 |
Why?
| | RNA, Messenger | 4 | 2021 | 2791 | 0.080 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2015 | 438 | 0.080 |
Why?
| | Kidney Cortex | 1 | 2010 | 27 | 0.080 |
Why?
| | Kinetics | 1 | 2014 | 1553 | 0.080 |
Why?
| | Hepatocytes | 2 | 2026 | 224 | 0.080 |
Why?
| | RNA, Small Interfering | 1 | 2013 | 633 | 0.080 |
Why?
| | Phosphoproteins | 1 | 2012 | 320 | 0.080 |
Why?
| | Glomerular Filtration Rate | 1 | 2014 | 745 | 0.080 |
Why?
| | Galectins | 1 | 2010 | 25 | 0.080 |
Why?
| | Kupffer Cells | 1 | 2010 | 52 | 0.080 |
Why?
| | Inflammation | 4 | 2026 | 2919 | 0.070 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2010 | 92 | 0.070 |
Why?
| | Arthritis, Rheumatoid | 1 | 2018 | 1185 | 0.070 |
Why?
| | Sequence Analysis, RNA | 2 | 2022 | 441 | 0.070 |
Why?
| | Biophysical Phenomena | 2 | 2021 | 67 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 2 | 2021 | 3926 | 0.070 |
Why?
| | Endosomes | 1 | 2010 | 139 | 0.070 |
Why?
| | Cell Membrane | 1 | 2013 | 701 | 0.070 |
Why?
| | STAT3 Transcription Factor | 2 | 2025 | 214 | 0.070 |
Why?
| | Cells, Cultured | 4 | 2019 | 4118 | 0.070 |
Why?
| | Hypertension | 1 | 2017 | 1272 | 0.070 |
Why?
| | Endothelial Cells | 1 | 2014 | 876 | 0.070 |
Why?
| | Mice, Transgenic | 3 | 2019 | 2134 | 0.070 |
Why?
| | Longevity | 2 | 2022 | 179 | 0.070 |
Why?
| | Heart Failure | 1 | 2021 | 2329 | 0.070 |
Why?
| | Middle Aged | 7 | 2026 | 36619 | 0.070 |
Why?
| | Cohort Studies | 3 | 2024 | 6077 | 0.060 |
Why?
| | X-Box Binding Protein 1 | 1 | 2026 | 16 | 0.060 |
Why?
| | Uteroglobin | 1 | 2026 | 31 | 0.060 |
Why?
| | Diacetyl | 1 | 2006 | 7 | 0.060 |
Why?
| | Nocodazole | 1 | 2006 | 17 | 0.060 |
Why?
| | Thiazolidines | 1 | 2006 | 13 | 0.060 |
Why?
| | Haemophilus Infections | 1 | 2026 | 45 | 0.060 |
Why?
| | Haemophilus influenzae | 1 | 2026 | 67 | 0.060 |
Why?
| | Aged | 5 | 2026 | 26432 | 0.060 |
Why?
| | Platelet Factor 4 | 1 | 2025 | 36 | 0.050 |
Why?
| | Receptors, Glucagon | 1 | 2025 | 27 | 0.050 |
Why?
| | Disease Progression | 2 | 2026 | 2867 | 0.050 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2025 | 96 | 0.050 |
Why?
| | Gluconeogenesis | 1 | 2025 | 81 | 0.050 |
Why?
| | Neovascularization, Physiologic | 1 | 2026 | 189 | 0.050 |
Why?
| | Platelet Activation | 1 | 2025 | 99 | 0.050 |
Why?
| | Blood Glucose | 2 | 2025 | 2360 | 0.050 |
Why?
| | Allyl Compounds | 1 | 2023 | 25 | 0.050 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2006 | 292 | 0.050 |
Why?
| | Biphenyl Compounds | 1 | 2023 | 67 | 0.050 |
Why?
| | NF-kappa B p50 Subunit | 1 | 2023 | 22 | 0.050 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2026 | 545 | 0.050 |
Why?
| | Ultrasonography, Doppler | 1 | 2024 | 122 | 0.050 |
Why?
| | NAD | 1 | 2023 | 80 | 0.050 |
Why?
| | Animals, Newborn | 1 | 2026 | 888 | 0.050 |
Why?
| | Neoplasm Proteins | 1 | 2026 | 444 | 0.050 |
Why?
| | Phenols | 1 | 2023 | 106 | 0.050 |
Why?
| | Desmoplakins | 1 | 2022 | 24 | 0.050 |
Why?
| | Immunophenotyping | 1 | 2024 | 324 | 0.050 |
Why?
| | Receptors, Immunologic | 1 | 2024 | 210 | 0.050 |
Why?
| | PQQ Cofactor | 1 | 2022 | 5 | 0.050 |
Why?
| | Infant, Newborn | 2 | 2026 | 6460 | 0.050 |
Why?
| | Recombinant Proteins | 2 | 2017 | 1361 | 0.050 |
Why?
| | PPAR alpha | 1 | 2022 | 56 | 0.040 |
Why?
| | HEK293 Cells | 2 | 2017 | 750 | 0.040 |
Why?
| | Pulmonary Alveoli | 1 | 2025 | 385 | 0.040 |
Why?
| | Matrix Metalloproteinases, Secreted | 1 | 2021 | 12 | 0.040 |
Why?
| | Gestational Age | 1 | 2025 | 990 | 0.040 |
Why?
| | ADAMTS4 Protein | 1 | 2021 | 16 | 0.040 |
Why?
| | Long Term Adverse Effects | 1 | 2021 | 13 | 0.040 |
Why?
| | Tyrphostins | 1 | 2021 | 18 | 0.040 |
Why?
| | Amphiregulin | 1 | 2021 | 27 | 0.040 |
Why?
| | Fetal Development | 1 | 2024 | 297 | 0.040 |
Why?
| | Blood Platelets | 1 | 2025 | 382 | 0.040 |
Why?
| | T-Lymphocytes | 1 | 2010 | 2012 | 0.040 |
Why?
| | Mitochondrial Proteins | 1 | 2023 | 263 | 0.040 |
Why?
| | Keratin-5 | 1 | 2021 | 43 | 0.040 |
Why?
| | Cattle | 1 | 2023 | 940 | 0.040 |
Why?
| | Hedgehog Proteins | 1 | 2022 | 194 | 0.040 |
Why?
| | Membrane Glycoproteins | 1 | 2024 | 495 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2025 | 784 | 0.040 |
Why?
| | Estrogens | 1 | 2024 | 364 | 0.040 |
Why?
| | Cilia | 1 | 2022 | 171 | 0.040 |
Why?
| | Substrate Specificity | 1 | 2021 | 389 | 0.040 |
Why?
| | C-Reactive Protein | 1 | 2023 | 429 | 0.040 |
Why?
| | Diet, High-Fat | 1 | 2022 | 267 | 0.040 |
Why?
| | Uterus | 1 | 2021 | 227 | 0.040 |
Why?
| | Flow Cytometry | 2 | 2014 | 1163 | 0.040 |
Why?
| | Maternal Exposure | 1 | 2021 | 189 | 0.040 |
Why?
| | Keratin-15 | 1 | 2019 | 15 | 0.040 |
Why?
| | Quinazolines | 1 | 2021 | 267 | 0.040 |
Why?
| | Positron-Emission Tomography | 1 | 2021 | 343 | 0.040 |
Why?
| | Premature Birth | 1 | 2024 | 390 | 0.040 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2022 | 642 | 0.040 |
Why?
| | Colloids | 1 | 2019 | 59 | 0.040 |
Why?
| | Liver Transplantation | 1 | 2026 | 751 | 0.040 |
Why?
| | Principal Component Analysis | 1 | 2020 | 192 | 0.040 |
Why?
| | Antioxidants | 1 | 2023 | 544 | 0.040 |
Why?
| | Receptors, Leukotriene | 1 | 2019 | 13 | 0.040 |
Why?
| | Expectorants | 1 | 2018 | 22 | 0.040 |
Why?
| | Arachidonate 5-Lipoxygenase | 1 | 2019 | 36 | 0.040 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2021 | 627 | 0.040 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2020 | 176 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2022 | 370 | 0.040 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2026 | 928 | 0.030 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 1 | 2018 | 45 | 0.030 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2022 | 295 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2020 | 496 | 0.030 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2021 | 429 | 0.030 |
Why?
| | Kidney Glomerulus | 1 | 2019 | 129 | 0.030 |
Why?
| | Ureteral Obstruction | 1 | 2019 | 62 | 0.030 |
Why?
| | Chenodeoxycholic Acid | 1 | 2017 | 11 | 0.030 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2019 | 162 | 0.030 |
Why?
| | Glomerular Mesangium | 1 | 2017 | 21 | 0.030 |
Why?
| | ErbB Receptors | 1 | 2021 | 636 | 0.030 |
Why?
| | Polycystic Kidney Diseases | 1 | 2019 | 82 | 0.030 |
Why?
| | Nucleotidases | 1 | 2017 | 6 | 0.030 |
Why?
| | Dietary Supplements | 1 | 2022 | 587 | 0.030 |
Why?
| | Gene Expression | 1 | 2022 | 1463 | 0.030 |
Why?
| | Mitochondrial Turnover | 1 | 2017 | 5 | 0.030 |
Why?
| | Mice, Inbred DBA | 1 | 2017 | 186 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 2019 | 790 | 0.030 |
Why?
| | Heart Function Tests | 1 | 2017 | 59 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2021 | 1712 | 0.030 |
Why?
| | Bacterial Load | 1 | 2017 | 68 | 0.030 |
Why?
| | DNA Methylation | 1 | 2022 | 725 | 0.030 |
Why?
| | Collagen | 1 | 2020 | 460 | 0.030 |
Why?
| | Urinalysis | 1 | 2017 | 82 | 0.030 |
Why?
| | Gelatin | 1 | 2017 | 56 | 0.030 |
Why?
| | Kidney Function Tests | 1 | 2017 | 156 | 0.030 |
Why?
| | Sodium-Glucose Transporter 2 | 1 | 2017 | 29 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2017 | 290 | 0.030 |
Why?
| | Pancreas | 1 | 2019 | 343 | 0.030 |
Why?
| | Hypolipidemic Agents | 1 | 2017 | 89 | 0.030 |
Why?
| | Albuminuria | 1 | 2017 | 190 | 0.030 |
Why?
| | RNA | 1 | 2022 | 926 | 0.030 |
Why?
| | DNA | 1 | 2022 | 1421 | 0.030 |
Why?
| | Odds Ratio | 1 | 2018 | 1077 | 0.030 |
Why?
| | Caloric Restriction | 1 | 2017 | 133 | 0.030 |
Why?
| | Cholesterol | 1 | 2017 | 411 | 0.030 |
Why?
| | Salmonella typhimurium | 1 | 2017 | 194 | 0.030 |
Why?
| | Triglycerides | 1 | 2017 | 527 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 2022 | 0.030 |
Why?
| | HeLa Cells | 1 | 2017 | 636 | 0.030 |
Why?
| | Tissue Scaffolds | 1 | 2017 | 223 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2015 | 139 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2017 | 384 | 0.030 |
Why?
| | Denys-Drash Syndrome | 1 | 2014 | 4 | 0.030 |
Why?
| | WT1 Proteins | 1 | 2014 | 12 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2017 | 508 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2015 | 371 | 0.030 |
Why?
| | Suppressor of Cytokine Signaling 3 Protein | 1 | 2013 | 11 | 0.030 |
Why?
| | Suppressor of Cytokine Signaling Proteins | 1 | 2013 | 20 | 0.030 |
Why?
| | Electrocardiography | 1 | 2017 | 667 | 0.030 |
Why?
| | Hydrogen Peroxide | 1 | 2015 | 337 | 0.020 |
Why?
| | Dextran Sulfate | 1 | 2013 | 93 | 0.020 |
Why?
| | Superoxide Dismutase | 1 | 2015 | 307 | 0.020 |
Why?
| | Infectious Disease Transmission, Vertical | 1 | 2015 | 188 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2013 | 150 | 0.020 |
Why?
| | Dextrans | 1 | 2013 | 83 | 0.020 |
Why?
| | Genotype | 1 | 2018 | 1879 | 0.020 |
Why?
| | Permeability | 1 | 2013 | 166 | 0.020 |
Why?
| | Adult | 3 | 2024 | 41087 | 0.020 |
Why?
| | Tissue Engineering | 1 | 2017 | 442 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2015 | 369 | 0.020 |
Why?
| | Transcription Factors | 1 | 2021 | 1730 | 0.020 |
Why?
| | Interleukins | 1 | 2014 | 248 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2013 | 345 | 0.020 |
Why?
| | DNA Primers | 1 | 2013 | 487 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2013 | 335 | 0.020 |
Why?
| | Myocytes, Cardiac | 1 | 2017 | 544 | 0.020 |
Why?
| | Caco-2 Cells | 1 | 2012 | 80 | 0.020 |
Why?
| | Neurons | 1 | 2021 | 1668 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 902 | 0.020 |
Why?
| | Infant | 1 | 2026 | 10114 | 0.020 |
Why?
| | Cytoskeletal Proteins | 1 | 2012 | 146 | 0.020 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2013 | 588 | 0.020 |
Why?
| | Blotting, Western | 1 | 2013 | 1177 | 0.020 |
Why?
| | Child, Preschool | 1 | 2026 | 11913 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2013 | 1298 | 0.020 |
Why?
| | Repressor Proteins | 1 | 2014 | 430 | 0.020 |
Why?
| | Blood Pressure | 1 | 2017 | 1765 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2013 | 1031 | 0.020 |
Why?
| | Interleukin-7 Receptor alpha Subunit | 1 | 2010 | 11 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2012 | 834 | 0.020 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2010 | 82 | 0.020 |
Why?
| | CD4 Antigens | 1 | 2010 | 136 | 0.020 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2012 | 457 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2010 | 209 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2017 | 3545 | 0.020 |
Why?
| | Carrier Proteins | 1 | 2012 | 728 | 0.020 |
Why?
| | Ligands | 1 | 2010 | 678 | 0.020 |
Why?
| | Monocytes | 1 | 2010 | 538 | 0.020 |
Why?
| | Leukocytes, Mononuclear | 1 | 2010 | 585 | 0.020 |
Why?
| | Risk Factors | 1 | 2021 | 10921 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2012 | 1130 | 0.010 |
Why?
| | Cytokines | 1 | 2013 | 2081 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2024 | 17438 | 0.010 |
Why?
| | Immunotherapy | 1 | 2010 | 671 | 0.010 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2010 | 1150 | 0.010 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2017 | 2623 | 0.010 |
Why?
| | Child | 1 | 2022 | 22693 | 0.010 |
Why?
| | Macrophages | 1 | 2010 | 1532 | 0.010 |
Why?
|
|
Dobrinskikh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|